Testimony issued by the General Accounting Office with an abstract that begins "Medicare provides valuable and extensive health care coverage for 40 million elderly and disabled beneficiaries. Nevertheless, significant gaps leave some beneficiaries vulnerable to sizeable out-of-pocket expenses. Medicare provides no limit on out-of-pocket spending and no coverage for most outpatient prescription drugs. Most beneficiaries have supplemental coverage that helps to fill Medicare coverage gaps and pay some out-of-pocket expenses. Privately purchased Medigap policies are a widely available source of supplemental coverage. The other sources--employer-sponsored policies, Medicare + Choice plans, and Medicaid--are not available to all beneficiaries. ...
The original Medicare Part D benefit included a gap in coverage, commonly known as the “doughnut hol...
A letter report issued by the Government Accountability Office with an abstract that begins "In 2006...
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to...
A letter report issued by the General Accounting Office with an abstract that begins "To protect the...
Testimony issued by the General Accounting Office with an abstract that begins "Medicare provides va...
This issue brief provides an overview of Medicare\u27s coverage gaps and the primary sources of supp...
Outlines the debate over proposals to limit coverage for Medicare enrollees who buy supplemental pri...
A letter report issued by the Government Accountability Office with an abstract that begins "GAO's a...
Nations are struggling to expand access to essential medications while curbing rising health and dru...
Testimony issued by the Government Accountability Office with an abstract that begins "Although priv...
Testimony issued by the General Accounting Office with an abstract that begins "In 1999, about 10 mi...
As policymakers look for savings from the Medicare program, some have proposed eliminating or discou...
ContextThe majority of Medicare drug benefits in managed care (Medicare + Choice) have annual dollar...
T he share of U.S. healthcare spending accounted for by prescription drugshas steadily increased sin...
Analyzes how three options for reforming Medicare supplemental insurance policies that help cover co...
The original Medicare Part D benefit included a gap in coverage, commonly known as the “doughnut hol...
A letter report issued by the Government Accountability Office with an abstract that begins "In 2006...
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to...
A letter report issued by the General Accounting Office with an abstract that begins "To protect the...
Testimony issued by the General Accounting Office with an abstract that begins "Medicare provides va...
This issue brief provides an overview of Medicare\u27s coverage gaps and the primary sources of supp...
Outlines the debate over proposals to limit coverage for Medicare enrollees who buy supplemental pri...
A letter report issued by the Government Accountability Office with an abstract that begins "GAO's a...
Nations are struggling to expand access to essential medications while curbing rising health and dru...
Testimony issued by the Government Accountability Office with an abstract that begins "Although priv...
Testimony issued by the General Accounting Office with an abstract that begins "In 1999, about 10 mi...
As policymakers look for savings from the Medicare program, some have proposed eliminating or discou...
ContextThe majority of Medicare drug benefits in managed care (Medicare + Choice) have annual dollar...
T he share of U.S. healthcare spending accounted for by prescription drugshas steadily increased sin...
Analyzes how three options for reforming Medicare supplemental insurance policies that help cover co...
The original Medicare Part D benefit included a gap in coverage, commonly known as the “doughnut hol...
A letter report issued by the Government Accountability Office with an abstract that begins "In 2006...
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to...